by Jordana Choucair | Jun 14, 2022 | Life Sciences
Senator Amy Klobuchar and Representative Katie Porter asked the Federal Trade Commission (FTC) to investigate whether Janssen Pharmaceuticals and Bristol Myers Squibb Co. coordinated “parallel” price increases on Xarelto and Eliquis. The letter noted that,...
by Jordana Choucair | Jun 14, 2022 | Life Sciences
The Food and Drug Administration (FDA) approved the first treatment for alopecia treatment that restores hair growth. The agency said that two trials showed that Eli Lilly & Co.’s Olumiant helped roughly 40 percent of the 1,2000 trial participants achieve...
by Jordana Choucair | Jun 14, 2022 | Life Sciences
An amendment to the Senate’s latest FDA user fee proposal calls on infant formula manufacturers to notify the agency within five business days of a disruption to their supply chain, an attempt to better guard against future formula shortages. The amendment...
by Jordana Choucair | Jun 13, 2022 | Life Sciences
The Food and Drug Administration (FDA) released briefing documents indicating that Moderna’s and Pfizer-BioNTech’s COVID-19 vaccines are both effective and safe for children 5 years old and younger. The FDA documents found that the Pfizer-BioNTech vaccine was...
by Jordana Choucair | Jun 13, 2022 | Life Sciences
The Biden administration is eyeing a policy change to push tobacco companies to cut nicotine levels in cigarettes sold in the U.S. to nonaddictive levels. The move would be the government’s biggest step to curb smoking since the Master Settlement Agreement in 1998....
by Jordana Choucair | Jun 13, 2022 | Life Sciences
Sanofi SA and GSK PLC said a late-stage trial showed their experimental COVID-19 booster shot activated a substantial boost in antibodies against several variants — including omicron BA.1 and BA.2 — compared to its first-generation booster shot. Sanofi and GSK also...
Recent Comments